Exscientia PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 15, 2022 / 02:05PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst

For our next session. My name is Mike Ryskin. I'm on the BofA Life Science Tools and Diagnostics team.

And for our next slide, we're joined by Exscientia. And with us we have Andrew Hopkins, Garry Pairaudeau and Mike Krams. Gentlemen, thank you.

Andrew L. Hopkins - Exscientia plc - Founder, CEO & Executive Director

Great to be here, Mike.

Questions and Answers:

Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst

Maybe just to set the floor a little bit. I think, given you're still a recent IPO, we always like to start with maybe a little bit of background, kind of -- tell us about yourself, tell us about the company, and sort of where you fit in?

Andrew L. Hopkins - Exscientia plc - Founder, CEO & Executive Director

Excellent. Thanks for the opportunity to be here today,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot